Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.73 |
| ▸ | ALPI | P09923 | 1/20 | 0.73 |
| ▸ | PKM | P14618 | 1/20 | 0.73 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.73 |
| ▸ | XIAP | P98170 | 1/20 | 0.73 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.61 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.60 |
| ▸ | LTA4H | P09960 | 1/20 | 0.58 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.56 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.56 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.56 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | LAP3 | P28838 | 3/20 | 0.52 |
| ▸ | ANPEP | P15144 | 1/20 | 0.52 |
| ▸ | CTSC | P53634 | 1/20 | 0.51 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenylalanine Amide SCHEMBL353251 | 1.00 | SLC7A5 (0.73) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine Amide SCHEMBL244302 | 1.00 | SLC7A5 (0.73) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine Amide SCHEMBL11349868 | 1.00 | SLC7A5 (0.73) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine Amide SCHEMBL11569548 | 0.98 | SLC7A5 (0.70) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine Amide SCHEMBL353593 | 0.98 | SLC7A5 (0.70) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine Amide SCHEMBL23002157 | 0.98 | SLC7A5 (0.70) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine Amide SCHEMBL7613303 | 0.98 | SLC7A5 (0.70) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine Amide SCHEMBL7613300 | 0.98 | SLC7A5 (0.70) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine Amide SCHEMBL31657718 | 0.98 | SLC7A5 (0.70) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine Amide SCHEMBL28278266 | 0.98 | SLC7A5 (0.70) | SLC7A5ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1472 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260027071-A1 | COMPOSITION FOR PROMOTING COLLAGEN PRODUCTION COMPRISING AMIDATED AMINO ACID | KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND (KR) | 2026-01-29 | — | — | US | claimed |
| EP-4680338-A1 | METHODS FOR PREPARING APTAMERS FOR SMALL MOLECULES | The Trustees Of Columbia University In The City Of New York (US) | 2026-01-21 | — | — | EP | claimed |
| US-20260015619-A1 | METHODS FOR PREPARING APTAMERS FOR SMALL MOLECULES | UNIV COLUMBIA (US) | 2026-01-15 | — | — | US | claimed |
| EP-3535310-B1 | ACROLEIN SCAVENGING IN PTF AND OTHER 1,3-PROPANEDIOL DERIVED POLYMERS | COCA COLA CO (US) | 2025-12-24 | — | — | EP | claimed |
| EP-4638785-A1 | A PCR-ELISA ANALOGOUS ANTIBODY-FREE METHOD FOR DETECTING A TARGET NUCLEIC ACID IN A SAMPLE | Universität Heidelberg (DE) | 2025-10-29 | — | — | EP | claimed |
| US-12312371-B2 | Optically-active 2-amino-phosphonoalkane acid, optically-active 2-amino-phosphonoalkane acid salt, and hydrates of these | NAHLS CORPORATION CO., LTD. (JP) | 2025-05-27 | — | — | US | claimed |
| WO-2025049554-A1 | HIF1A OR GLUT1 INHIBITION IN INFLAMMATORY SKIN DISEASES | NEW YORK UNIVERSITY (US) | 2025-03-06 | — | — | WO | claimed |
| CN-119430746-A | Water-permeable color asphalt concrete and preparation method thereof | 河北雄安容西混凝土有限公司 | 2025-02-14 | — | — | CN | claimed |
| EP-4483868-A1 | COMPOSITION FOR PROMOTING COLLAGEN PRODUCTION COMPRISING AMIDATED AMINO ACID | Boo, Yong Chool (KR) | 2025-01-01 | — | — | EP | claimed |
| EP-3613750-B1 | OPTICALLY-ACTIVE 2-AMINO-PHOSPHONOALKANE ACID, OPTICALLY-ACTIVE 2-AMINO-PHOSPHONOALKANE ACID SALT, AND HYDRATES OF THESE | UNIV KYOTO (JP) | 2024-12-11 | — | — | EP | claimed |
| WO-1991001369-A1 | PREPARATION OF HUMAN ADHERENT LYMPHOKINE-ACTIVATED KILLER (A-LAK) CELLS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-02-07 | — | — | WO | claimed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | claimed |
| EP-0236163-B1 | DERIVATIVES OF N-ALPHA-SUBSTITUTED N-ALPHA-ARYLSULFONYLAMINOACYL P-AMIDINOPHENYLALANINAMIDES, THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND THEIR INTERMEDIATES | SANOFI (FR) | 1990-10-03 | — | — | EP | claimed |
| US-4918196-A | HEATING IN PRESENCE OF STRONG BASE, SOLVENT OR SOLVENT-FREE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1990-04-17 | — | — | US | claimed |
| EP-0188947-B1 | REDUCED PEPTIDES, INHIBITORS OF GASTRIC SECRETION, PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SANOFI S.A. (FR) | 1989-08-02 | — | — | EP | claimed |
| US-4761495-A | Method relating to preparation of aspartyl peptides | ISOCHEM S.A. (FR) | 1988-08-02 | — | — | US | claimed |
| EP-0081838-B1 | CYCLOHEXYL AND PHENYL SUBSTITUTED ENKEPHALINS | G.D. Searle & Co. (US) | 1988-04-27 | — | — | EP | claimed |
| EP-0236163-A1 | Derivatives of N-alpha-substituted N-alpha-arylsulfonylaminoacyl p-amidinophenylalaninamides, their preparation, their use as medicaments and their intermediates | SANOFI (FR) | 1987-09-09 | — | — | EP | claimed |
| EP-0193113-A1 | Process for optically isomerizing optically active alpha-amino acid amides and process for producing optically active alpha-amino acids | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1986-09-03 | — | — | EP | claimed |
| EP-0188947-A1 | Reduced peptides, inhibitors of gastric secretion, preparation process and pharmaceutical compositions containing them | SANOFI S.A. (FR) | 1986-07-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015619-A1 | METHODS FOR PREPARING APTAMERS FOR SMALL MOLECULES | HNMT, GNMT, PNMT | SLC7A5 307/4885ALPI 3634/4885PKM 2076/4885 |
| US-20260027071-A1 | COMPOSITION FOR PROMOTING COLLAGEN PRODUCTION COMPRISING AMIDATED AMINO ACID | COL2A1, COL14A1, GLS | SLC7A5 1146/4885ALPI 799/4885PKM 2412/4885 |
| US-12312371-B2 | Optically-active 2-amino-phosphonoalkane acid, optically-active 2-amino-phosphonoalkane acid salt, and hydrates of these | AASDHPPT, PHYKPL, PKD2 | SLC7A5 494/4885ALPI 769/4885PKM 1132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.